tirzepatide versus semaglutide weight loss caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs Semaglutide | Comparing

GLP-1RAs are associated with reduced hepatic insulin resistance, which contributes to enhanced glucose homeostasis and improved metabolic profiles in patients with metabolic disorder syndrome (Lin et al., 2024)

High concentration (10 mg/mL): fewer units, less precision At 10 mg/mL, each unit on a U-100 syringe represents 0.1 mg of tirzepatide

Those with health conditions or on medication should consult a healthcare provider before use

Experimental records should document the product name, batch number, date received, storage conditions and all preparation steps to support reproducibility

identifiers LY3437943, NOP2Y096GV (UNII)

The cost of the 9-mg and 25-mg doses is $299 per month, which is $50 cheaper than the injections